循環器ジャーナル70巻1号

2022年01月発行

特集 心筋症診療のフロントライン—概念から最新の治療まで Ⅰ章　心筋症の概念

心筋症の概念

著者： 北岡裕章¹

所属機関： ¹高知大学医学部老年病・循環器内科学

ページ範囲：P.6 - P.12

Point
・心筋症は「心機能障害を伴う心筋疾患」と定義される．
・病型として拡張型心筋症，肥大型心筋症，拘束型心筋症，不整脈原性右室心筋症に分けられる．
・二次性心筋症は，心機能障害の原因が明らかな心筋症や全身疾患に伴う心筋疾患である．病因ごとに予後や治療が異なるため，正確な鑑別診断が重要である．

参考文献

1）McKenna WJ, Maron BJ, Thiene G : Classification, Epidemiology, and Global Burden of Cardiomyopathies. Circ Res 121 : 722-730, 2017

2）Report of the WHO/ISFC Task Force on the definition and classification of cardiomyopathies. Br Heart J 44 : 672-673, 1980

3）Richardson P, McKenna W, Bristow M, et al : Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classifica-tion of cardiomyopathies. Circulation 93 : 841-842, 1996

4）Maron BJ, Towbin JA, Thiene G, et al : Contemporary definitions and classification of the cardiomyopathies : an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee ; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups ; and Council on Epidemiology and Prevention. Circulation 113 : 1807-1816, 2006

5）Elliott P, Andersson B, Arbustini E, et al : Classification of the cardiomyopathies : a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29 : 270-276, 2008

6）日本循環器学会/日本心不全学会合同ガイドライン　心筋症診療ガイドライン（2018年改訂版）．https://www.j-circ.or.jp/cms/wp-content/uploads/2018/08/JCS2018_tsutsui_kitaoka.pdf（2021年8月閲覧）

7）Arbustini, E, Narula, N, Tavazzi L, et al : The MOGE（S）Classification of Cardiomyopathy for Clinicians. J Am Coll Cardiol 64 : 304-318, 2014

8）厚生労働省難治性疾患克服研究事業特発性心筋症調査研究班，北畠顕，友池仁暢（編）：心筋症：診断の手引きとその解説．かりん舎，2005

9）Devesa A, Camblor Blasco A, Pello Lázaro AM, et al : Prevalence of transthyretin amyloidosis in patients with heart failure and no left ventricular hypertrophy. ESC Heart Fail 8 : 2856-2865, 2021

10）森田啓行：遺伝子から心筋症をみる．日内会誌103 : 285-292, 2014

11）Tobita T, Nomura S, Fujita T, et al : Genetic basis of cardiomyopathy and the genotypes involved in prognosis and left ventricular reverse remodeling. Sci Rep 8 : 1998, 2018

12）Harper AW, Goel A, Grace C, et al : Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity. Nature Genetics 53 : 135-142, 2021

13）Kitaoka H, Kubo T, Doi YL : Hypertrophic Cardiomyopathy-A Heterogeneous and Lifelong Disease in the Real World. Cir J 84 : 1218-1226, 2020

14）Bosman LP, Te Riele ASJM : Arrhythmogenic right ventricular cardiomyopathy : a focused update on diagnosis and risk stratification. Heart 2021. doi : 10.1136/heartjnl-2021-319113

15）北岡裕章（編）：循環器診療コンプリート　心筋症．p 12，学研メディカル秀潤社，2021